MA35283B1 - Produits de recombinaison destinés à inactiver le gène p0 et leur utilisation - Google Patents

Produits de recombinaison destinés à inactiver le gène p0 et leur utilisation

Info

Publication number
MA35283B1
MA35283B1 MA36709A MA36709A MA35283B1 MA 35283 B1 MA35283 B1 MA 35283B1 MA 36709 A MA36709 A MA 36709A MA 36709 A MA36709 A MA 36709A MA 35283 B1 MA35283 B1 MA 35283B1
Authority
MA
Morocco
Prior art keywords
inactivating
gene
recombinant products
sequence
recombinant
Prior art date
Application number
MA36709A
Other languages
English (en)
Inventor
Elodie Klein
Véronique Graff
David Gilmer
Véronique Brault
Guy Weyens
Marc Lefebvre
Original Assignee
SESVanderHave NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44907563&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA35283(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by SESVanderHave NV filed Critical SESVanderHave NV
Publication of MA35283B1 publication Critical patent/MA35283B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Environmental Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cette invention concerne une séquence de nucléotides du virus bmyv p0 qui, une fois transcrite dans une cellule, est capable de former une séquence arn double brin auto-complémentaire.
MA36709A 2011-06-23 2014-01-22 Produits de recombinaison destinés à inactiver le gène p0 et leur utilisation MA35283B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11171196A EP2537936A1 (fr) 2011-06-23 2011-06-23 Constructions de silençage du gène P0 et leur utilisation
PCT/EP2012/061436 WO2012175420A1 (fr) 2011-06-23 2012-06-15 Produits de recombinaison destinés à inactiver le gène p0 et leur utilisation

Publications (1)

Publication Number Publication Date
MA35283B1 true MA35283B1 (fr) 2014-07-03

Family

ID=44907563

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36709A MA35283B1 (fr) 2011-06-23 2014-01-22 Produits de recombinaison destinés à inactiver le gène p0 et leur utilisation

Country Status (17)

Country Link
US (2) US9932603B2 (fr)
EP (2) EP2537936A1 (fr)
CN (1) CN103635581B (fr)
CA (1) CA2839371A1 (fr)
CL (1) CL2013003466A1 (fr)
DK (1) DK2723873T4 (fr)
EA (1) EA029359B1 (fr)
ES (1) ES2647077T5 (fr)
HU (1) HUE035070T2 (fr)
LT (1) LT2723873T (fr)
MA (1) MA35283B1 (fr)
PL (1) PL2723873T5 (fr)
PT (1) PT2723873T (fr)
SI (1) SI2723873T1 (fr)
TN (1) TN2013000498A1 (fr)
UA (1) UA114603C2 (fr)
WO (1) WO2012175420A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150291969A1 (en) * 2014-01-30 2015-10-15 Chromatin, Inc. Compositions for reduced lignin content in sorghum and improving cell wall digestibility, and methods of making the same
CN110938645A (zh) * 2019-12-17 2020-03-31 中国农业大学 一种甘蔗黄叶病毒运动蛋白表达纯化方法及其多克隆抗血清的制备
US20230183733A1 (en) 2020-05-20 2023-06-15 KWS SAAT SE & Co. KGaA Multiple virus resistance

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE129745T1 (de) 1990-03-02 1995-11-15 Biocem Regenerierung und genetische transformation der zuckerrübe.
US7663024B2 (en) * 1998-07-10 2010-02-16 Sesvanderhave, N.V. P15 hairpin constructs and use
EP1029923A1 (fr) 1999-01-27 2000-08-23 D.J. Van Der Have B.V. Procédé conférant aux betteraves sucrières une résistance à une infection par BNYVV
WO2009141446A1 (fr) 2008-05-23 2009-11-26 Syngenta Participations Ag Plantes de betterave sucrière transgéniques
EP2367414A1 (fr) 2008-12-19 2011-09-28 Syngenta Participations AG Événement de betterave sucrière transgénique gm rz13

Also Published As

Publication number Publication date
HUE035070T2 (en) 2018-05-02
CN103635581A (zh) 2014-03-12
DK2723873T4 (da) 2020-04-20
PL2723873T3 (pl) 2018-01-31
CA2839371A1 (fr) 2012-12-27
EA029359B1 (ru) 2018-03-30
SI2723873T1 (sl) 2017-11-30
ES2647077T3 (es) 2017-12-19
CL2013003466A1 (es) 2014-08-08
US20140317779A1 (en) 2014-10-23
DK2723873T3 (da) 2017-11-20
US9932603B2 (en) 2018-04-03
EP2723873A1 (fr) 2014-04-30
EP2723873B1 (fr) 2017-08-09
TN2013000498A1 (fr) 2015-03-30
LT2723873T (lt) 2018-02-12
CN103635581B (zh) 2016-08-10
EP2537936A1 (fr) 2012-12-26
EP2723873B2 (fr) 2020-01-15
US10662438B2 (en) 2020-05-26
PT2723873T (pt) 2017-10-04
UA114603C2 (uk) 2017-07-10
PL2723873T5 (pl) 2020-07-13
ES2647077T5 (es) 2020-10-05
WO2012175420A1 (fr) 2012-12-27
US20180265888A1 (en) 2018-09-20
EA201490160A1 (ru) 2014-04-30

Similar Documents

Publication Publication Date Title
MX2021006635A (es) Composiciones de acido ribonucleico de interferencia (arni) contra el virus de la hepatitis b (hbv) y metodos de uso de estas.
MX2018007237A (es) Proteinas de cápside modificadas para un suministro mejorado de vectores de parvovirus.
WO2015042308A3 (fr) Inhibiteurs du vih à base d'arn
EA201391394A1 (ru) Композиции и способы ингибирования экспрессии генов вируса гепатита в
EA201790698A1 (ru) Новые сайты интеграции cho и их применения
EP3334843A4 (fr) Séquençage monomoléculaire d'adn plasmatique
MX2019006413A (es) Composiciones de arni de serpinc1 y metodos de uso de las mismas.
MX2021009118A (es) Composiciones y metodos para inhibir la expresion del gen alas1.
EP2895626A4 (fr) Séquençage précis du génome de cellules individuelles par l'amplification et le séquençage d'un seul brin
BR112013030824A8 (pt) Bactéria gram-positiva, ácido necleico recombinante, composição farmacêutica e vetor
EP3481853A4 (fr) Perturbation génétique du complexe protéique dégradosome de l'arn
EP3323893A4 (fr) Complexe d'acide nucléique inhibant l'expression du gène béta2gpi
IN2014KN02769A (fr)
TN2014000327A1 (en) Oligonucleotides for modulating gene expression and uses thereof
EP3978614A3 (fr) Construction génique à vecteur unique comprenant des gènes de l'insuline et de la glucokinase
HK1259060A1 (zh) 抑制腎素原基因或腎素原受體基因表達的單鏈核酸分子及其用途
NZ703095A (en) Oligonucleotide chelate complex-polypeptide compositions and methods
MA35283B1 (fr) Produits de recombinaison destinés à inactiver le gène p0 et leur utilisation
EP2852606A4 (fr) Modulation de l'expression génique à médiation par un activateur arn
BR112013027098A2 (pt) produtos de vírus recombinante e métodos para inibição de expressão de miotilina
JP2014532403A5 (fr)
WO2015123592A3 (fr) Particules d'arn recombiné et méthodes d'utilisation
EP3362580A4 (fr) Génotypage multiallèles de polymorphismes mononucléotidiques et d'insertions-délétions
WO2013148212A8 (fr) Acides nucléiques destinés à une amplification d'acide nucléique
SG10201505354PA (en) Dna element having the activity of enhancing foreign gene expression